---
title: 'Recruiting Coordinator & Scheduler – 6 month contract at Rezolute'
canonical: 'https://feeny.ai/job/recruiting-coordinator-scheduler-6-month-contract-rezolute-redwood-city-x0gcanx9q7vf'
type: 'job'
last_seen: '2026-11-06'
---

# Recruiting Coordinator & Scheduler – 6 month contract at Rezolute

- **Company:** Rezolute
- **Location:** Redwood City, CA
- **Employment:** contract
- **Work type:** hybrid
- **Posted:** 2026-11-01
- **Last confirmed live:** 2026-11-06
- **Apply:** https://jobs.lever.co/rezolutebio/467f1018-42a7-481c-afa8-50e532b0bfd6

## Job description

Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute’s mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity.

Position Overview: As a Recruiting Coordinator & Scheduler, you will support Talent Acquisition operations. You will manage complex interview schedules, coordinate high-touch candidate experiences, and ensure seamless logistics throughout the hiring pipeline. Working closely with hiring managers, scientific leaders, and talent acquisition teams, you will represent our employer brand to candidates and help maintain a high standard of candidate care.

This is a hybrid contract position requiring onsite presence three days per week.

## Key Responsibilities

- Interview Logistics & Scheduling: Coordinate high-volume, multi-stage interviews (phone screens, technical presentations, panel interviews, and executive debriefs) across multiple time zones using Zoom/Teams and calendar tools.
- Applicant Tracking System (ATS) Management: Maintain accurate data, move candidates through workflows, and maintain accurate candidate status updates and  changes in Lever.
- Candidate Experience: Serve as the primary point of contact for candidates regarding interview schedules, travel arrangements (if applicable), and reimbursement logistics.
- Hiring Manager & Interviewer Support: Send calendar invites,  related material and information to internal interviewers to ensure timely candidate feedback.
- Offer & Onboarding Support: Assist with generating offer letters, initiating background checks, and transitioning hired candidates to the HR onboarding team.
- Process Improvement: Identify opportunities to streamline scheduling workflows and improve overall talent acquisition efficiency.

## Qualifications & Requirements

- Experience: Minimum of 3 years of hands-on experience in recruiting coordination, talent acquisition operations, or complex executive scheduling.
- Industry background: Prior experience in the biopharmaceutical, biotechnology, life sciences, or healthcare sectors strongly preferred.
- ATS Expertise: Direct, hands-on experience using Applicant Tracking Systems required; Lever experience strongly preferred.
- Tools Proficiency: Advanced proficiency with Google Workspace (Gmail, Calendar, Docs/Sheets) and/or Microsoft Outlook/Teams, alongside video conferencing tools (Zoom, MS Teams).
- Communication & Interpersonal Skills: Outstanding verbal and written communication skills with a strong candidate-first customer service orientation.
- Detail-Oriented & Adaptable: Exceptional organizational skills with the ability to manage competing priorities, handle last-minute schedule shifts gracefully, and maintain confidentiality.

Rezolute (RZLT) currently anticipates the base salary for the Recruiting Coordinator & Scheduler role could range from $40.00 per hour to $60.00 per hour and will depend in part on the successful candidate’s qualifications for the role, including education and experience

## About Rezolute

## Company Overview
- **One-liner**: Rezolute is a late-stage rare disease biotechnology company developing ersodetug, a monoclonal antibody therapy for hypoglycemia caused by congenital and tumor hyperinsulinism.
- **Entity Type**: Public (Nasdaq: RZLT)
- **Headquarters**: Redwood City, California, United States (with an additional office in Louisville)
- **Founded**: Not publicly available (IPO 2012)
- **Founders**: Not publicly available

## Core Business
- **Primary industry**: Biotechnology – rare disease therapeutics
- **Target customers**: B2B – healthcare providers, patients, and payers; focuses on addressing severe unmet medical needs in hyperinsulinism
- **Mission/purpose**: Significantly improve outcomes for individuals with hypoglycemia caused by hyperinsulinism ([rezolutebio.com – About](https://rezolutebio.com/job-openings/))

## Products & Services
- **Ersodetug (lead candidate)**: An intravenously administered human monoclonal antibody that allosterically binds to the insulin receptor, down‑modulating insulin action to restore normal glucose levels. Being developed for two indications:
  - **Congenital Hyperinsulinism (sunRIZE Phase 3 study)** – completed enrollment (May 2025) with 62 participants; topline results expected December 2025.
  - **Tumor Hyperinsulinism (upLIFT Phase 3 study)** – initiated mid‑2025; FDA agreed to a single‑arm open‑label design; topline results expected second half 2026.
  - Designations: Orphan Drug (US/EU), Rare Pediatric Disease, Breakthrough Therapy (US), PRIME (EU), ILAP (UK) ([ir.rezolutebio.com – 10-K](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf))

## Market Standing
- **Valuation/Market Cap**: $317.7 million (as of recent data, per LinkedIn) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Key Metric (Public)**: Annual revenue of $14.1 million (likely from grants or collaboration revenue; no product revenue yet) ([linkedin.com](https://linkedin.com/company/rezolute))
- **Notable Investors/Partners**: Not publicly available – company is publicly traded and does not disclose a lead investor list. Key partners include clinical trial sites and regulatory agencies (FDA, EMA).
- **Growth Signals**:
  - Headcount: 50 employees (+2.9% YoY) ([linkedin.com](https://linkedin.com/company/rezolute))
  - Phase 3 sunRIZE study fully enrolled; topline data pending December 2025.
  - Phase 3 upLIFT study enrolling with streamlined design; data expected second half 2026.
  - FDA granted Breakthrough Therapy Designation for tumor HI in May 2025.
  - Multiple regulatory designations accelerating development pathway.

## Competitive Advantages
- **Unique mechanism**: Ersodetug acts downstream from beta cells at the insulin receptor, allowing it to potentially treat all forms of hyperinsulinism (genetic or acquired) regardless of underlying cause.
- **Dosing convenience**: Half‑life >2 weeks enables monthly intravenous administration.
- **Regulatory momentum**: Orphan Drug, Rare Pediatric Disease, Breakthrough Therapy, PRIME, and ILAP designations provide expedited review, potential priority review voucher, and closer FDA/EMA collaboration.
- **Pivotal data catalysts**: Two Phase 3 studies read out within ~12‑18 months, creating clear value inflection points.

## Strategic Focus
- Execute the two ongoing Phase 3 trials (sunRIZE in congenital HI, upLIFT in tumor HI).
- Assuming positive topline data from sunRIZE, submit a Biologics License Application (BLA) to the FDA for ersodetug in mid‑2026.
- Continue to build commercial and medical affairs infrastructure (recent job postings indicate hires in Commercial Operations, Marketing, Payer Strategy, and Supply Chain) ([rezolutebio.com – Job Openings](https://rezolutebio.com/job-openings/)).

## Why Work Here
- **Mission‑driven**: Employees work on therapies for ultra‑rare, life‑threatening conditions with high unmet medical need.
- **Benefits**: Comprehensive health/dental/vision insurance, competitive salaries, annual bonus, 401(k) with company match, tuition assistance, on‑site meals, flexible spending accounts ([rezolutebio.com – Benefits](https://rezolutebio.com/job-openings/)).
- **Work environment**: Hybrid/office policy not explicitly stated; roles are based in Redwood City (HQ) and Louisville. Recent openings include remote-friendly functions? Not confirmed.
- **Growth opportunity**: Small company (~50 people) entering late‑stage development and pre‑commercial build‑out – employees can have broad impact and career advancement.
- **Engineering culture**: For biotech, the focus is on clinical operations, regulatory, and commercial roles rather than traditional engineering. IT positions (Business System Engineer) exist.

## Sources
1. [linkedin.com – Rezolute company page](https://linkedin.com/company/rezolute)
2. [rezolutebio.com – Job Openings & Benefits](https://rezolutebio.com/job-openings/)
3. [ir.rezolutebio.com – SEC 10-K Filing (September 2025)](https://ir.rezolutebio.com/sec-filings/content/0001104659-25-090848/0001104659-25-090848.pdf)
4. [rezolutebio.com – Leadership page](https://rezolutebio.com/leadership/)

## Other roles at Rezolute

- [Director – Biostatistics](https://feeny.ai/job/director-biostatistics-rezolute-redwood-city-rsdg74z82vkk) — Redwood City, CA
- [Medical Science Liaison / Senior Medical Science Liaison - Oncology / Rare Endocrine Disorders](https://feeny.ai/job/medical-science-liaison-senior-medical-science-liaison-oncology-rare-endocrine-bhs2782j7gtm)
- [Medical Science Liaison / Senior Medical Science Liaison - Pediatric Endocrinology / Rare Metabolic Disorders](https://feeny.ai/job/medical-science-liaison-senior-medical-science-liaison-pediatric-endocrinology-pvkvqb4szfae)
- [Contract Recruiter (Biopharmaceutical Industry) 6 month contract](https://feeny.ai/job/contract-recruiter-biopharmaceutical-industry-6-month-contract-rezolute-redwood-jvpc3bn5g8t2) — Redwood City, CA
- [Senior Manager, Scientific Communications & Medical Education](https://feeny.ai/job/senior-manager-scientific-communications-medical-education-rezolute-redwood-city-363wemxkxap1) — Redwood City, CA
- [Head of Product Launch Program Management (Rare Disease)](https://feeny.ai/job/head-of-product-launch-program-management-rare-disease-rezolute-redwood-city-7qka6sahvk1h) — Redwood City, CA
- [Associate Director, Medical Affairs Operations](https://feeny.ai/job/associate-director-medical-affairs-operations-rezolute-redwood-city-gg2p7j75sszn) — Redwood City, CA
- [Vice President, Global Manufacturing](https://feeny.ai/job/vice-president-global-manufacturing-rezolute-redwood-city-wcyqhfyet1yw) — Redwood City, CA
- [Vice President, Global Supply Chain](https://feeny.ai/job/vice-president-global-supply-chain-rezolute-redwood-city-q0dngx787mdk) — Redwood City, CA
- [Medical Writer II, Clinical/Regulatory](https://feeny.ai/job/medical-writer-ii-clinical-regulatory-rezolute-redwood-city-h43j74mshd1b) — Redwood City, CA